Cell-free nucleic acids as biomarkers in cancer patients

作者: Heidi Schwarzenbach , Dave S. B. Hoon , Klaus Pantel

DOI: 10.1038/NRC3066

关键词:

摘要: … Such investigations will be crucial if we are to use cfDNA as a prognostic biomarker, as will the isolation and processing of cfNA to defined standards (discussed below). …

参考文章(182)
D C García-Olmo, R Ruiz-Piqueras, D García-Olmo, Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. Histology and Histopathology. ,vol. 19, pp. 575- 583 ,(2004) , 10.14670/HH-19.575
M Mannik, W Emlen, Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clinical and Experimental Immunology. ,vol. 56, pp. 185- 192 ,(1984)
Elizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen, James G. Herman, Stephen B. Baylin, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nature Genetics. ,vol. 21, pp. 103- 107 ,(1999) , 10.1038/5047
Pierre Laurent-Puig, Florence Coulet, Daniel Brasnu, Arnauld Cabelguenne, Philippe Beaune, Helene Blons, Thierry Lecomte, Jessica Zucman, Olivier Laccourreye, Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Research. ,vol. 60, pp. 707- 711 ,(2000)
Armando E. Giuliano, Bret Taback, Nora M. Hansen, Sherry Shu, Dave S. B. Hoon, Frederick R. Singer, Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Cancer Research. ,vol. 63, pp. 1884- 1887 ,(2003)
Wichai Pornthanakasem, Kanjana Shotelersuk, Wichai Termrungruanglert, Narin Voravud, Somchai Niruthisard, Apiwat Mutirangura, Human papillomavirus DNA in plasma of patients with cervical cancer BMC Cancer. ,vol. 1, pp. 2- 2 ,(2001) , 10.1186/1471-2407-1-2
David Sidransky, Susan Booker, C. Rahj Robinson, Stanley R. Hamilton, Kenji Hibi, Jin Jen, Li Wu, Molecular Detection of Genetic Alterations in the Serum of Colorectal Cancer Patients Cancer Research. ,vol. 58, pp. 1405- 1407 ,(1998)
R. Kefford, H. Arkenau, M. P. Brown, M. Millward, J. R. Infante, G. V. Long, D. Ouellet, M. Curtis, P. F. Lebowitz, G. S. Falchook, Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors. Journal of Clinical Oncology. ,vol. 28, pp. 8503- 8503 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.8503
C Matuschek, E Bölke, G Lammering, PA Gerber, M Peiper, W Budach, H Taskin, HB Prisack, G Schieren, K Orth, H Bojar, Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease European Journal of Medical Research. ,vol. 15, pp. 277- 286 ,(2010) , 10.1186/2047-783X-15-7-277
I. H.N. Wong, Winnie Yeo, W. Y. Lau, P. J. Johnson, Yuk-ming Dennis Lo, Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients Clinical Cancer Research. ,vol. 6, pp. 3516- 3521 ,(2000)